🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of rapcabt...
Status
Recruiting
Location
University Of Colorado
Start Date
2025-03-13
Trial ID
NCT06868290
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of rapcabt...
Status
Recruiting
Location
University Of Alabama
Start Date
2024-09-04
Trial ID
NCT06581198
Treatments Being Tested
This is an open-label, multi-center, non-confirmatory study to assess the s...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2024-12-12
Trial ID
NCT06675864
Treatments Being Tested
A study to assess safety, cellular kinetics and exploratory efficacy of rap...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2025-06-20
Trial ID
NCT07048197
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety and tolerabil...
Status
Recruiting
Location
UCLA
Start Date
2024-10-29
Trial ID
NCT06655896
Treatments Being Tested
This is an open-label, multi-center, non-confirmatory study to assess the s...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2025-02-24
Trial ID
NCT06617793
Treatments Being Tested
A Phase 2, randomized, open-label, controlled study to evaluate the efficac...
Status
Active Not Recruiting
Location
University Of Alabama
Start Date
2024-12-17
Trial ID
NCT06665256
Treatments Being Tested
This is a phase 1b clinical trial to assess the efficacy of rapcabtagene au...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09
Trial ID
NCT07443137
Treatments Being Tested
This is a phase I/II study to evaluate the feasibility, safety and prelimin...
Status
Active Not Recruiting
Location
University of California LA
Start Date
2019-06-26
Trial ID
NCT03960840
Treatments Being Tested